Concepedia

Tomasz Świtaj

TŚ

Statistics

Publications

51

Citations

1.8K

H-Index

24

Active since

1999

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Medical University of Warsaw

Mossakowski Medical Research Institute, Polish Academy of Sciences

Polish Academy of Sciences

KU Leuven

Tomasz Świtaj is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in oncology, medicine, and malignant neoplasms.

ORCID

Publications per year

1999–2025

51

Publications

51

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

Piotr Rutkowski, Elżbieta Bylina, Agnieszka Woźniak et al. · European Journal of Surgical Oncology · 2011 · 170 citations

, , +12

Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells

Ahmad Jalili, Marcin Makowski, Tomasz Świtaj et al. · Clinical Cancer Research · 2004 · 149 citations · Full text

, , +17

Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.

Wojciech Feleszko, Ewa Bałkowiec-Iskra, Anna Czajka et al. · PubMed · 2000 · 134 citations

, , +15

Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas

Hanna Koseła-Paterczyk, Milena Szacht, Tadeusz Morysiński et al. · European Journal of Surgical Oncology · 2014 · 110 citations

, , +6

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

Piotr Rutkowski, Elżbieta Bylina, Anna Klimczak et al. · BMC Cancer · 2012 · 95 citations · Full text

, , +17

1–5 of 51